Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial

per Elgadi, Mabrouk M., Piliero, Peter J.
Publicat 2012

In Vitro-In Vivo Model for Evaluating the Antiviral Activity of Amprenavir in Combination with Ritonavir Administered at 600 and 100 Milligrams, Respectively, Every 12 Hours

per Preston, Sandra L., Piliero, Peter J., Bilello, John A., Stein, Daniel S., Symonds, William T., Drusano, George L.
Publicat 2003

Pharmacokinetic Assessment of Nevirapine and Metabolites in Human Immunodeficiency Virus Type 1-Infected Patients with Hepatic Fibrosis

per Cammett, Anna Maria, MacGregor, Thomas R., Wruck, Jan M., Felizarta, Franco, Miailhes, Patrick, Mallolas, Josep, Piliero, Peter J.
Publicat 2009

Interaction between Fosamprenavir, with and without Ritonavir, and Nevirapine in Human Immunodeficiency Virus-Infected Subjects

per DeJesus, Edwin, Piliero, Peter J., Summers, Kim, Wire, Mary Beth, Stein, Daniel S., Masterman, Amanda, Lou, Yu, Min, Sherene S., Shelton, Mark J.
Publicat 2006

Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Tipranavir/Ritonavir in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone

per Bruce, R. Douglas, Altice, Frederick L., Moody, David E., Lin, Shen-Nan, Fang, Wenfang B., Sabo, John P., Wruck, Jan M., Piliero, Peter J., Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H.
Publicat 2009